Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Continuously reducing excess blood glucose is a primary goal for the management of type 2 diabetes (T2D). Most patients with T2D require glucose-lowering medications to achieve and maintain adequate glycemic control; however, treatment failure may occur, limiting treatment options. Glucagon-like pep...

Descripción completa

Detalles Bibliográficos
Autores principales: Courtney, Hamish, Nayar, Rahul, Rajeswaran, Chinnadorai, Jandhyala, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357070/
https://www.ncbi.nlm.nih.gov/pubmed/28331351
http://dx.doi.org/10.2147/DMSO.S126763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357070/
https://www.ncbi.nlm.nih.gov/pubmed/28331351
http://dx.doi.org/10.2147/DMSO.S126763

Ejemplares similares